top of page
Copy of Vibrant IP.png

VIP-3663

PathO3Gen Solutions | UVZone® Shoe-Sole Sanitizing Technology

An automated UV-C and ozone system designed to reduce microorganisms on shoe soles at facility entry and controlled-transition points.

  • The portfolio covers step-on stations that sanitize the soles of footwear with ultraviolet light and ozone. As the patent record describes them, a user stands on foot or shoe supports above a housing that holds UV emitters. Germicidal UV-C passes through the supports to irradiate the sole, while shorter-wavelength UV converts oxygen in the surrounding air into ozone, which the specification characterizes as reducing microorganisms that UV light alone does not readily reduce. Seller materials describe lamps rated 185 to 254 nm and a selectable 6, 8 or 10 second cycle.


    Shoe soles carry contamination past hand-hygiene and gowning steps, and a 2016 systematic review found no effective method for treating shoe soles. Doorway controls today rely on chemical footbaths, brush washers or single-use overboots.


    As characterized in the patent abstracts, later members of the original family add user identification for recording each use, and an activated-carbon layer that converts residual ozone into lower-concentration gases. Two 2023 families keep the emitters continuously powered to extend their life, with louvers that open under the user's weight, electromechanically in one family and by mechanical linkage in the other, and close when the user steps off. A handheld family holds UV emitters behind a window and a shutter biased closed, which a trigger opens for instant-on use. A separate family applies UV-C and ozone to wound and incision sites and object surfaces, with proximity or surface detectors permitting emission only when the device is in position.


    Applications span hospital entries, pharmaceutical gowning areas, food and dairy plants and livestock biosecurity. A PathO3Gen-published case study states that AdventHealth Connerton added nine UVZone stations in February 2019. Separately, an NSF International Applied Research Center controlled carrier study reported reductions of at least 3 log for seven of eight tested organisms at an 8-second exposure, with those seven results ranging from 3.25 to 4.62 log. The study’s highest reported result, a 5.16-log reduction in Candida auris, occurred at a 10-second exposure.


    The portfolio is available for sale or license, including exclusive or non-exclusive licenses by field of use or region.

  • The IP and assets available for sale or license include:

    Shoe-Sole Sanitizing Stations (Family 1, priority 2010)

    US 8,624,202 B2, US 8,617,479 B2, US 8,696,985 B2, US 8,784,731 B2

    UV-C and Ozone Wound-Site and Surface Treatment  (Family 2, priority 2017)

    US 10,335,505 B2, US 10,596,282 B2, US 11,638,836 B2, CA 3,071,955 C, WO 2019/040245 A1

    UV Emitter-Life Footwear Sanitizers (Families 3 and 4, priority 2023)

    US 12,151,040 B2, US 12,496,366 B2, EP 4683680 A1, EP 4456929 A1, US 2025/0041464 A1

    Instant-On Handheld UV Sanitizer (Family 5, priority 2023)

    US 12,115,271 B1, EP 4456930 A1, US 2024/0424158 A1

    Shoe-Sole Sanitizing Station Designs

    US D837,997 S, US D1,013,202 S, US D1,013,893 S, CA 196812 S, CL CVE 1898887, EC DI-2021-141, EU 008028195-0001, EU 008028195-0002, PE 000865-2021, CO NC2020/0013644

  • Other Public Data Room Materials Available at VIP-3663 Public Data Room for UVZone® Shoe-Sole Sanitizing Technology:

    • Introductory Materials

    • Patents, Applications, and Trademarks

    • Patent File Histories

    • Patent Assignments & Ownership

    • Market Analysis

    • Images & Videos

    • Research Reports


    Additional Materials (available upon signing a mutual non-disclosure agreement):

    • Due Diligence Review

    • Current Technology & Product

    • Future Technology & Products

    • Legal Compliance

    • Financials


  • Pricing guidance for this transaction may be available. All parties interested in the IP above are authorized to contact Leon Castro at Vibrant IP, LLC at leon@vibrantip.com

bottom of page